Predict your next investment

ApoGen Biotechnologies company logo
HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Series A - II | Alive

Total Raised


Last Raised

$4M | 3 yrs ago

About ApoGen Biotechnologies

ApoGen Biotechnologies is a biotechnology company focused on the development of therapeutics targeting drivers of cancer genomic mutation. ApoGen is building upon technologies developed at the University of Minnesota to develop drugs that block a key pathway that causes drug resistance. ApoGen's drug discovery and development efforts are directed toward selective and potent small molecule inhibitors of the APOBEC family of enzymes, which are DNA cytosine deaminases and an endogenous source of DNA mutation in cancer.

ApoGen Biotechnologies Headquarter Location

2815 Eastlake Avenue East Suite 300

Seattle, Washington, 98102,

United States


Latest ApoGen Biotechnologies News

ApoGen expands series A to $11M

Sep 3, 2018

ApoGen expands series A to $11M 11:13 AM PDF Drug-resistant cancer company ApoGen Biotechnologies Inc. raised an additional $4 million on Aug. 23 from M Ventures and existing investors in its series A round, bringing the round's total to $11 million. M Ventures is the venture arm... Read the full 166 word article User Sign in

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ApoGen Biotechnologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ApoGen Biotechnologies is included in 4 Expert Collections, including Pharma Startups.


Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.


Cancer Therapeutics

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.



5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

ApoGen Biotechnologies Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ApoGen Biotechnologies Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.